290
Participants
Start Date
April 30, 2003
Primary Completion Date
July 31, 2004
Study Completion Date
July 31, 2004
Buprenorphine transdermal patch
Buprenorphine transdermal patch 5 mcg/h applied for 7-day wear
Buprenorphine transdermal patch
Buprenorphine transdermal patch 10 mcg/h applied for 7-day wear
Buprenorphine transdermal patch
Buprenorphine transdermal patch 20 mcg/h applied for 7-day wear
Beth Israel/Dept. of Pain, New York
Research Facility, Cresson
Altoona Center for Clinical Research, Duncansville
University Orthopedics & Sport Medicine Center, State College
Research Facility, West Reading
Hilltop Medical Center, Virginia Beach
Research Facility, Winston-Salem
Low Country Rheumatology, PA, Charleston
Research Facility, Marietta
Allergy, Asthma, Arthritis & Lung, Daytona Beach
University Clinical Research Deland, DeLand
Coastal Medical Research, Orange City
Research Facility, Plantation
Research Facility, West Palm Beach
Research Facility, Jupiter
Research Facility, Atlantis
Primary Care Medical Center, Murray
Research Facility, Columbus
Research Facility, Evansville
Great Lakes Family Care, Cadillac
Research Facility, Traverse City
Central Plains Clin-Brown Site, Watertown
Research Facility, Dallas
Research Facility, Harker Heights
Research Facility, Seguin
Research Facility, San Antonio
Research Facility, Westminster
Research Facility, Denver
Granger Medical Clinic, West Valley City
Arthrocare, Arthritis Care and Research, Phoenix
Arizona Rheumatology Ctr and Phoenix Ctr for Clinical Research, Phoenix
Arizona Research Center, Phoenix
Vista Medical Research Inc., Mesa
Research Facility, Tucson
Orange County Clinical Research, Cypress
San Diego Arthritis & Osteoporosis Medical Clinic, San Diego
Research Facility, San Diego
Advanced Pain Medicine, Bakersfield
Research Facility, San Francisco
Research Facility, Bellevue
Internal Medicine Northwest, Tacoma
Research Facility, Bridgeport
Purdue Pharma LP
INDUSTRY